Matches in Wikidata for { <http://www.wikidata.org/entity/Q65546027> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q65546027 description "assaig clínic" @default.
- Q65546027 description "clinical trial" @default.
- Q65546027 description "clinical trial" @default.
- Q65546027 description "clinical trial" @default.
- Q65546027 description "clinical trial" @default.
- Q65546027 description "ensaio clínico" @default.
- Q65546027 description "ensayo clínico" @default.
- Q65546027 description "ensayu clínicu" @default.
- Q65546027 description "essai clinique" @default.
- Q65546027 description "klinisch onderzoek" @default.
- Q65546027 description "клінічне випробування" @default.
- Q65546027 name "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)" @default.
- Q65546027 name "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis" @default.
- Q65546027 type Item @default.
- Q65546027 label "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)" @default.
- Q65546027 label "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis" @default.
- Q65546027 prefLabel "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)" @default.
- Q65546027 prefLabel "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis" @default.
- Q65546027 P1050 Q65546027-0E832301-A17B-485B-A5A4-3D00A8D3B6C3 @default.
- Q65546027 P1050 Q65546027-76BC0084-E8DF-41ED-AA9A-B9B4D38DCF75 @default.
- Q65546027 P1132 Q65546027-0E914235-5728-4E58-8B9D-33FF6935612A @default.
- Q65546027 P1476 Q65546027-6E165DC3-7D4B-4005-8876-9EBE8250763B @default.
- Q65546027 P17 Q65546027-52D92149-1791-4BF8-BD5D-066A8B9DDB6E @default.
- Q65546027 P1813 Q65546027-1B557A09-116D-4B79-8358-639D3D8FFBD3 @default.
- Q65546027 P2899 Q65546027-2FB5D1E9-8F5D-4C18-8096-4CA1AEA15B65 @default.
- Q65546027 P3098 Q65546027-BA4A840A-6886-4D54-BC73-A06A486AC885 @default.
- Q65546027 P31 Q65546027-D23ED5CA-533A-4887-8313-9C64A05D836C @default.
- Q65546027 P4135 Q65546027-BAFC9228-BBE0-4B5B-8F9E-B6C620D57A66 @default.
- Q65546027 P580 Q65546027-BDE651F4-1D34-49E6-BC6F-FD18635BDE12 @default.
- Q65546027 P582 Q65546027-0D5EAAF2-31C1-41C3-81D3-FDD50A42A2B3 @default.
- Q65546027 P6099 Q65546027-0C89DBAF-6006-42D3-9AAB-E5C95F0AB915 @default.
- Q65546027 P8363 Q65546027-752810D8-171F-4301-8BC2-4C3F0E91EBE5 @default.
- Q65546027 P1050 Q281490 @default.
- Q65546027 P1050 Q318005 @default.
- Q65546027 P1132 "+221" @default.
- Q65546027 P1476 "A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate (120 μg and 240 μg) and 2 Different Daily Doses of Minirin® Tablet (0.2 mg and 2 x 0.2 mg) in Children and Adolescents With Primary Nocturnal Enuresis (PNE)" @default.
- Q65546027 P17 Q142 @default.
- Q65546027 P1813 "PALAT" @default.
- Q65546027 P2899 "+5" @default.
- Q65546027 P3098 "NCT00209261" @default.
- Q65546027 P31 Q30612 @default.
- Q65546027 P4135 "+15" @default.
- Q65546027 P580 "2004-12-01T00:00:00Z" @default.
- Q65546027 P582 "2005-08-01T00:00:00Z" @default.
- Q65546027 P6099 Q42825046 @default.
- Q65546027 P8363 Q78089383 @default.